Lipocine Inc

NASDAQ:LPCN   3:59:57 PM EDT
1.05
-0.04 (-3.67%)
Products

Lipocine Reports FDA Affirmation Of Class 1 NDA Resubmission For TLANDO

Published: 09/28/2021 12:33 GMT
Lipocine Inc (LPCN) - Lipocine Announces FDA Affirmation of Class 1 NDA Resubmission for Tlando®.
Lipocine Inc - Resubmission of NDA is a Necessary Requirement to Receive Final Approval From FDA and is Expected to Occur on January 28, 2022.